PROKR1 and metabolic disease: Further investigations are warranted to unravel the precise mechanisms involved and to explore the broader metabolic implications of celecoxib‐PROKR1 signalling, which may have implications for therapeutic interventions in muscle‐related conditions and metabolic disorders.